Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents

Thrombosis, or blood clot formation, and its sequelae remain a leading cause of morbidity and mortality, and recurrent thrombosis is common despite current optimal therapy. Protein disulfide isomerase (PDI) is an oxidoreductase that has recently been shown to participate in thrombus formation. While...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Jasuja, Reema, Passam, Freda H., Kennedy, Daniel R., Kim, Sarah H., van Hessem, Lotte, Lin, Lin, Bowley, Sheryl R., Joshi, Sucharit S., Dilks, James R., Furie, Bruce, Furie, Barbara C., Flaumenhaft, Robert
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Clinical Investigation 2012
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366406/
https://ncbi.nlm.nih.gov/pubmed/22565308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI61228
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια